Clinical Trial Update: Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids [Phase 4]

View source ↗

Summary

Phase 4 trial assessing prevention of NMDA antagonist-induced psychosis in children; the study is completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance-induced Psychosis

Snippet

Sponsor: Washington University School of Medicine | Conditions: Psychoses, Substance-Induced | Phase 4 | Status: COMPLETED | Results posted: 2010-04-07